Literature DB >> 19706535

Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse.

Huan-Yuan Chen1, Agnes Fermin, Santosh Vardhana, I-Chun Weng, Kin Fong Robin Lo, En-Yuh Chang, Emanual Maverakis, Ri-Yao Yang, Daniel K Hsu, Michael L Dustin, Fu-Tong Liu.   

Abstract

We have investigated the function of endogenous galectin-3 in T cells. Galectin-3-deficient (gal3(-/-)) CD4(+) T cells secreted more IFN-gamma and IL-4 than gal3(+/+)CD4(+) T cells after T-cell receptor (TCR) engagement. Galectin-3 was recruited to the cytoplasmic side of the immunological synapse (IS) in activated T cells. In T cells stimulated on supported lipid bilayers, galectin-3 was primarily located at the peripheral supramolecular activation cluster (pSMAC). Gal3(+/+) T cells formed central SMAC on lipid bilayers less effectively and adhered to antigen-presenting cells less firmly than gal3(-/-) T cells, suggesting that galectin-3 destabilizes the IS. Galectin-3 expression was associated with lower levels of early signaling events and phosphotyrosine signals at the pSMAC. Additional data suggest that galectin-3 potentiates down-regulation of TCR in T cells. By yeast two-hybrid screening, we identified as a galectin-3-binding partner, Alix, which is known to be involved in protein transport and regulation of cell surface expression of certain receptors. Co-immunoprecipitation confirmed galectin-3-Alix association and immunofluorescence analysis demonstrated the translocation of Alix to the IS in activated T cells. We conclude that galectin-3 is an inhibitory regulator of T-cell activation and functions intracellularly by promoting TCR down-regulation, possibly through modulating Alix's function at the IS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706535      PMCID: PMC2732795          DOI: 10.1073/pnas.0903497106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Galectins in apoptosis.

Authors:  Daniel K Hsu; Ri-Yao Yang; Fu-Tong Liu
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 2.  Modulation of the immunological synapse: a key to HIV-1 pathogenesis?

Authors:  Oliver T Fackler; Andres Alcover; Olivier Schwartz
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

Review 3.  Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1.

Authors:  Ken Fujii; James H Hurley; Eric O Freed
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

4.  Mechanisms for segregating T cell receptor and adhesion molecules during immunological synapse formation in Jurkat T cells.

Authors:  Yoshihisa Kaizuka; Adam D Douglass; Rajat Varma; Michael L Dustin; Ronald D Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

Review 5.  Protein-glycan interactions in the control of innate and adaptive immune responses.

Authors:  Yvette van Kooyk; Gabriel A Rabinovich
Journal:  Nat Immunol       Date:  2008-06       Impact factor: 25.606

6.  Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression.

Authors:  Huan-Yuan Chen; Bhavya B Sharma; Lan Yu; Riaz Zuberi; I-Chun Weng; Yuko Kawakami; Toshiaki Kawakami; Daniel K Hsu; Fu-Tong Liu
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

Review 7.  T-cell activation through immunological synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Immunol Rev       Date:  2008-02       Impact factor: 12.988

Review 8.  Galectins: structure, function and therapeutic potential.

Authors:  Ri-Yao Yang; Gabriel A Rabinovich; Fu-Tong Liu
Journal:  Expert Rev Mol Med       Date:  2008-06-13       Impact factor: 5.600

9.  Regulation of alternative macrophage activation by galectin-3.

Authors:  Alison C MacKinnon; Sarah L Farnworth; Philip S Hodkinson; Neil C Henderson; Kirsten M Atkinson; Hakon Leffler; Ulf J Nilsson; Christopher Haslett; Stuart J Forbes; Tariq Sethi
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

10.  Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery.

Authors:  Jez G Carlton; Juan Martin-Serrano
Journal:  Science       Date:  2007-06-07       Impact factor: 47.728

View more
  71 in total

1.  Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.

Authors:  Chuan Tong; Yajing Zhang; Yang Liu; Xingyu Ji; Wenying Zhang; Yelei Guo; Xiao Han; Dongdong Ti; Hanren Dai; Chunmeng Wang; Qingming Yang; Wanli Liu; Yao Wang; Zhiqiang Wu; Weidong Han
Journal:  Blood       Date:  2020-10-01       Impact factor: 22.113

2.  Galectin-3 regulates inflammasome activation in cholestatic liver injury.

Authors:  Jijing Tian; Guoxiang Yang; Huan-Yuan Chen; Daniel K Hsu; Alexey Tomilov; Kristin A Olson; Ali Dehnad; Sarah R Fish; Gino Cortopassi; Bin Zhao; Fu-Tong Liu; M Eric Gershwin; Natalie J Török; Joy X Jiang
Journal:  FASEB J       Date:  2016-09-14       Impact factor: 5.191

Review 3.  Galectin-3 and the skin.

Authors:  Larissa Larsen; Huan-Yuan Chen; Jun Saegusa; Fu-Tong Liu
Journal:  J Dermatol Sci       Date:  2011-08-11       Impact factor: 4.563

4.  Analysis of the intracellular role of galectins in cell growth and apoptosis.

Authors:  Daniel K Hsu; Ri-Yao Yang; Jun Saegusa; Fu-Tong Liu
Journal:  Methods Mol Biol       Date:  2015

5.  New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling.

Authors:  Monika Bambouskova; Iva Polakovicova; Ivana Halova; Gautam Goel; Lubica Draberova; Viktor Bugajev; Aivi Doan; Pavol Utekal; Agnes Gardet; Ramnik J Xavier; Petr Draber
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

6.  Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice.

Authors:  Marina Miletic Kovacevic; Nada Pejnovic; Slobodanka Mitrovic; Nemanja Jovicic; Ivica Petrovic; Nebojsa Arsenijevic; Miodrag L Lukic; Biljana Ljujic
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 7.  Engineering galectin-glycan interactions for immunotherapy and immunomodulation.

Authors:  Shaheen A Farhadi; Gregory A Hudalla
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

Review 8.  The regulatory power of glycans and their binding partners in immunity.

Authors:  Jenny L Johnson; Mark B Jones; Sean O Ryan; Brian A Cobb
Journal:  Trends Immunol       Date:  2013-02-26       Impact factor: 16.687

9.  Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancer.

Authors:  Tatsuo Shimura; Masahiko Shibata; Kenji Gonda; Takahiro Nakajima; Shun Chida; Masaru Noda; Satoshi Suzuki; Izumi Nakamura; Shinji Ohki; Seiichi Takenoshita
Journal:  Biomed Rep       Date:  2016-05-30

10.  Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6.

Authors:  Sheng-Fan Wang; Ching-Han Tsao; Yu-Ting Lin; Daniel K Hsu; Meng-Lin Chiang; Chia-Hui Lo; Fan-Ching Chien; Peilin Chen; Yi-Ming Arthur Chen; Huan-Yuan Chen; Fu-Tong Liu
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.